Industrious Pharmaceuticals
Warp speed is amazoning pharma practices and protocols.
The Long Path to Normal
Survey respondents reflect on the state and future of the bio/pharma employment.
Changes Afoot: 2022 Outlook for Pharma and its People
An obvious theme for 2021 has been COVID-19, but the next 12 months will see industry and its people experiencing further change.
Addressing the Training Gap for Single-Use Technologies
Workforce training is crucial for biopharmaceutical manufacturing.
The Need for Speed: How Operation Warp Speed Shifted the Pharma Industry
A new focus on speed to market creates challenges for facility design and construction.
Taste and Appearance: Selecting the Right Excipients
Dosage form and patient needs drive excipient choice.
Tackling the Big Issue of Solubility
Poor solubility remains a big issue for drug development and, as such, is driving innovation in approaches and use of novel technologies to help overcome the associated challenges.
Biologics Testing Highlights Need for Analytical Skills
There is need for training personnel in various analytical skill sets for biologic drug substance testing.
Outsourcing’s Race Toward Novelty
Recent developments in the outsourcing industry include a focus on early development services, biosimilar production, and RNA technology.
Regulating Digital Therapeutics
DTx manufacturers are taking advantage of the new regulatory flexibility, afforded by the COVID-19 pandemic, to pilot new products and generate real-world evidence to support regulatory filing and reimbursement.
Continued Process Verification for Cleaning Validation– Challenges and Pitfalls
Continued process verification for a cleaning validation program begins once the validation study is complete.
Quality Still a Priority
As regulators balance pandemic tasks and rethink procedures, quality at manufacturing facilities is still a priority.
Good Manufacturing Practice on Demand?
Siegfried Schmitt, vice president Technical at Parexel, discusses the difficulty of operating non-GMP and GMP quality systems in the same facility.
Major Challenges Ahead for FDA and Pharma
To maintain smooth operations, FDA is relying on swift reauthorization of industry-paid user fee programs.
Hot Picks for 2022
Overall, 2021 proved to be another good year for drug approvals in Europe, albeit with a slight disappointment for Alzheimer’s patients, but what should industry be watching out for in 2022?
January Makes Your Head Spin
January is the kind of month that can make your head spin.
Digital Integration Platform
Scitara’s Scientific Integration Platform (SIP) establishes a flexible, adaptable framework that facilitates a fully connected laboratory.
Next-Generation Cas9 Proteins
Thermo Fisher's Invitrogen TrueCut HiFi Cas9 Protein significantly reduces off-target events while retaining maximum on-target editing efficiency.
Sustainable Biowaste Treatment System
The MicroEDS BioWaste Treatment System can process between 150 to 500 L of waster per day.
ROSS Dual-Shaft Mixer with High Shear Rotor/Stator
ROSS incorporated a high shear rotor/stator into its Dual-Shaft Mixer to meet more intense shearing and homogenization requirements.
